NO983540D0 - Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering - Google Patents

Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering

Info

Publication number
NO983540D0
NO983540D0 NO983540A NO983540A NO983540D0 NO 983540 D0 NO983540 D0 NO 983540D0 NO 983540 A NO983540 A NO 983540A NO 983540 A NO983540 A NO 983540A NO 983540 D0 NO983540 D0 NO 983540D0
Authority
NO
Norway
Prior art keywords
cilansetron
pharmaceutical
stabilized against
against racemization
preparations stabilized
Prior art date
Application number
NO983540A
Other languages
English (en)
Other versions
NO323229B1 (no
NO983540L (no
Inventor
Ingo Bonnacker
Hartmut Koehn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO983540D0 publication Critical patent/NO983540D0/no
Publication of NO983540L publication Critical patent/NO983540L/no
Publication of NO323229B1 publication Critical patent/NO323229B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19983540A 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater NO323229B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
DE19813661A DE19813661A1 (de) 1997-08-01 1998-03-27 Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron

Publications (3)

Publication Number Publication Date
NO983540D0 true NO983540D0 (no) 1998-07-31
NO983540L NO983540L (no) 1999-02-02
NO323229B1 NO323229B1 (no) 2007-02-05

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983540A NO323229B1 (no) 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater

Country Status (29)

Country Link
US (1) US5977127A (no)
EP (1) EP0895782B1 (no)
JP (1) JP4324260B2 (no)
KR (1) KR100515201B1 (no)
CN (1) CN1117565C (no)
AR (1) AR010178A1 (no)
AT (1) ATE283706T1 (no)
AU (1) AU743043B2 (no)
BR (1) BR9803730A (no)
CA (1) CA2244389C (no)
CZ (1) CZ295072B6 (no)
DE (2) DE19813661A1 (no)
DK (1) DK0895782T3 (no)
DZ (1) DZ2560A1 (no)
ES (1) ES2234051T3 (no)
HK (1) HK1017611A1 (no)
HU (1) HUP9801712A3 (no)
ID (1) ID20685A (no)
IL (1) IL125403A (no)
NO (1) NO323229B1 (no)
NZ (1) NZ331083A (no)
PL (1) PL191767B1 (no)
PT (1) PT895782E (no)
RU (1) RU2199318C2 (no)
SK (1) SK284916B6 (no)
TR (1) TR199801432A3 (no)
TW (1) TW509570B (no)
UA (1) UA62924C2 (no)
ZA (1) ZA986715B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
ATE326216T1 (de) * 2001-03-26 2006-06-15 Novartis Pharma Gmbh Pharmazeutische zusammensetzung enthaltend ein schlecht wasserlösliches staurosporin, eine oberflächenaktive substanz und ein wasserlösliches polymer
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
BRPI0406748A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Método de tratamento de náusea, vÈmito e ânsia de vÈmito ou qualquer combinação destes em um paciente que necessite do mesmo e composição farmacêutica
ES2290741T3 (es) * 2003-04-04 2008-02-16 Dynogen Pharmaceuticals Inc. Metodo de tratamiento de trastornos del tracto urinario inferior.
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US20110152342A1 (en) * 2008-08-14 2011-06-23 Hiroshi Uchida Stabilized pharmaceutical composition
JPWO2021100728A1 (no) 2019-11-20 2021-05-27

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (en) * 1987-06-29 1993-11-03 Duphar International Research B.V Anellated indole derivatives
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
NO323229B1 (no) 2007-02-05
IL125403A0 (en) 1999-03-12
SK284916B6 (sk) 2006-02-02
JP4324260B2 (ja) 2009-09-02
AU743043B2 (en) 2002-01-17
SK100998A3 (en) 1999-02-11
TR199801432A2 (xx) 1999-02-22
ES2234051T3 (es) 2005-06-16
ID20685A (id) 1999-02-18
PL191767B1 (pl) 2006-06-30
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15
CN1207292A (zh) 1999-02-10
TW509570B (en) 2002-11-11
CZ295072B6 (cs) 2005-05-18
IL125403A (en) 2001-11-25
DE59812317D1 (de) 2005-01-05
CZ236798A3 (cs) 1999-02-17
NZ331083A (en) 2000-01-28
HK1017611A1 (en) 1999-11-26
HU9801712D0 (en) 1998-09-28
DK0895782T3 (da) 2005-01-03
EP0895782A2 (de) 1999-02-10
ATE283706T1 (de) 2004-12-15
TR199801432A3 (tr) 1999-02-22
AR010178A1 (es) 2000-05-17
EP0895782A3 (de) 2001-01-31
JPH1192369A (ja) 1999-04-06
PT895782E (pt) 2005-02-28
KR100515201B1 (ko) 2005-12-09
CA2244389A1 (en) 1999-02-01
DZ2560A1 (fr) 2003-02-15
ZA986715B (en) 1999-02-04
DE19813661A1 (de) 1999-02-04
HUP9801712A3 (en) 2001-08-28
PL327786A1 (en) 1999-02-15
CA2244389C (en) 2008-01-15
CN1117565C (zh) 2003-08-13
US5977127A (en) 1999-11-02
NO983540L (no) 1999-02-02
AU7863098A (en) 1999-02-11
EP0895782B1 (de) 2004-12-01
BR9803730A (pt) 2000-03-28
RU2199318C2 (ru) 2003-02-27
HUP9801712A2 (hu) 1999-04-28

Similar Documents

Publication Publication Date Title
DK114797A (da) Farmaceutiske præparater til intranasal administrering
NO954146D0 (no) Belagte farmasöytiske preparater
ID24654A (id) Formulasi farmasi omeprazola
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
ATE367150T1 (de) Arzneimittel
BR9610396A (pt) Formulação farmacêutica
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
NO983540D0 (no) Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering
NO974934L (no) 10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
DE69926012D1 (de) Arzneizubereitungen
DE69811367T2 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653D0 (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
FI973230A (fi) Uusi farmaseuttinen formulaatio
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
DE59805373D1 (de) Nephroprotektive Arzneimittel
DE69829245D1 (de) Nimesulid enthaltende, Topisch anwendbare Arzneipräparate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees